Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	Anemia	Blood and lymphatic system disorders	Ixabepilone	11	15
other	Anemia	Blood and lymphatic system disorders	Ixabepilone Plus Cetuximab	18	25
other	Fatigue	General disorders	Ixabepilone	10	15
other	Fatigue	General disorders	Ixabepilone Plus Cetuximab	21	25
serious	Peripheral neuropathy	Nervous system disorders	Ixabepilone	2	15
serious	Peripheral neuropathy	Nervous system disorders	Ixabepilone Plus Cetuximab	2	25
serious	Rash	Skin and subcutaneous tissue disorders	Ixabepilone	0	15
serious	Rash	Skin and subcutaneous tissue disorders	Ixabepilone Plus Cetuximab	1	25
serious	GI Events	Gastrointestinal disorders	Ixabepilone	0	15
serious	GI Events	Gastrointestinal disorders	Ixabepilone Plus Cetuximab	1	25
serious	Neutropenia	Blood and lymphatic system disorders	Ixabepilone	0	15
serious	Neutropenia	Blood and lymphatic system disorders	Ixabepilone Plus Cetuximab	2	25

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01097642/events